Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease

Gene and protein expression of programmed death‐ligand 1 (PD‐L1) are prognostic in early breast cancer (BC), but their prognostic information is inconsistent at least in some biological subgroups. The validated prognostic gene signatures (GS) in BC are mainly based on proliferation and estrogen rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Zerdes, Ioannis, Sifakis, Emmanouil G., Matikas, Alexios, Chrétien, Sebastian, Tobin, Nicholas P., Hartman, Johan, Rassidakis, George Z., Bergh, Jonas, Foukakis, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191187/
https://www.ncbi.nlm.nih.gov/pubmed/32115850
http://dx.doi.org/10.1002/1878-0261.12654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191187/
https://www.ncbi.nlm.nih.gov/pubmed/32115850
http://dx.doi.org/10.1002/1878-0261.12654

Ejemplares similares